世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5520
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・スウェーデンポルフィリン症治療の市場動向
・企業の競争状況、市場シェア
・スウェーデンポルフィリン症治療の種類別市場規模（350mg、313mg）
・スウェーデンポルフィリン症治療の用途別市場規模（病院、薬局）
・スウェーデンポルフィリン症治療の北米市場規模2016-2027（アメリカ、カナダ）
・スウェーデンポルフィリン症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・スウェーデンポルフィリン症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・スウェーデンポルフィリン症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・スウェーデンポルフィリン症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott）
・結論

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.

Market Analysis and Insights: Global Swedish Porphyria Treatment Market
The global Swedish Porphyria Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Swedish Porphyria Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Swedish Porphyria Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Swedish Porphyria Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Swedish Porphyria Treatment market.

Global Swedish Porphyria Treatment Scope and Market Size
Swedish Porphyria Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Swedish Porphyria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
350mg
313mg

Segment by Application
Hospital
Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Swedish Porphyria Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 350mg
1.2.3 313mg
1.3 Market by Application
1.3.1 Global Swedish Porphyria Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Swedish Porphyria Treatment Market Perspective (2016-2027)
2.2 Swedish Porphyria Treatment Growth Trends by Regions
2.2.1 Swedish Porphyria Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Swedish Porphyria Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Swedish Porphyria Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Swedish Porphyria Treatment Industry Dynamic
2.3.1 Swedish Porphyria Treatment Market Trends
2.3.2 Swedish Porphyria Treatment Market Drivers
2.3.3 Swedish Porphyria Treatment Market Challenges
2.3.4 Swedish Porphyria Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Swedish Porphyria Treatment Players by Revenue
3.1.1 Global Top Swedish Porphyria Treatment Players by Revenue (2016-2021)
3.1.2 Global Swedish Porphyria Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Swedish Porphyria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Swedish Porphyria Treatment Revenue
3.4 Global Swedish Porphyria Treatment Market Concentration Ratio
3.4.1 Global Swedish Porphyria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swedish Porphyria Treatment Revenue in 2020
3.5 Swedish Porphyria Treatment Key Players Head office and Area Served
3.6 Key Players Swedish Porphyria Treatment Product Solution and Service
3.7 Date of Enter into Swedish Porphyria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Swedish Porphyria Treatment Breakdown Data by Type
4.1 Global Swedish Porphyria Treatment Historic Market Size by Type (2016-2021)
4.2 Global Swedish Porphyria Treatment Forecasted Market Size by Type (2022-2027)

5 Swedish Porphyria Treatment Breakdown Data by Application
5.1 Global Swedish Porphyria Treatment Historic Market Size by Application (2016-2021)
5.2 Global Swedish Porphyria Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Swedish Porphyria Treatment Market Size (2016-2027)
6.2 North America Swedish Porphyria Treatment Market Size by Type
6.2.1 North America Swedish Porphyria Treatment Market Size by Type (2016-2021)
6.2.2 North America Swedish Porphyria Treatment Market Size by Type (2022-2027)
6.2.3 North America Swedish Porphyria Treatment Market Size by Type (2016-2027)
6.3 North America Swedish Porphyria Treatment Market Size by Application
6.3.1 North America Swedish Porphyria Treatment Market Size by Application (2016-2021)
6.3.2 North America Swedish Porphyria Treatment Market Size by Application (2022-2027)
6.3.3 North America Swedish Porphyria Treatment Market Size by Application (2016-2027)
6.4 North America Swedish Porphyria Treatment Market Size by Country
6.4.1 North America Swedish Porphyria Treatment Market Size by Country (2016-2021)
6.4.2 North America Swedish Porphyria Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Swedish Porphyria Treatment Market Size (2016-2027)
7.2 Europe Swedish Porphyria Treatment Market Size by Type
7.2.1 Europe Swedish Porphyria Treatment Market Size by Type (2016-2021)
7.2.2 Europe Swedish Porphyria Treatment Market Size by Type (2022-2027)
7.2.3 Europe Swedish Porphyria Treatment Market Size by Type (2016-2027)
7.3 Europe Swedish Porphyria Treatment Market Size by Application
7.3.1 Europe Swedish Porphyria Treatment Market Size by Application (2016-2021)
7.3.2 Europe Swedish Porphyria Treatment Market Size by Application (2022-2027)
7.3.3 Europe Swedish Porphyria Treatment Market Size by Application (2016-2027)
7.4 Europe Swedish Porphyria Treatment Market Size by Country
7.4.1 Europe Swedish Porphyria Treatment Market Size by Country (2016-2021)
7.4.2 Europe Swedish Porphyria Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Swedish Porphyria Treatment Market Size (2016-2027)
8.2 Asia-Pacific Swedish Porphyria Treatment Market Size by Type
8.2.1 Asia-Pacific Swedish Porphyria Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Swedish Porphyria Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Swedish Porphyria Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Swedish Porphyria Treatment Market Size by Application
8.3.1 Asia-Pacific Swedish Porphyria Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Swedish Porphyria Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Swedish Porphyria Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Swedish Porphyria Treatment Market Size by Region
8.4.1 Asia-Pacific Swedish Porphyria Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Swedish Porphyria Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Swedish Porphyria Treatment Market Size (2016-2027)
9.2 Latin America Swedish Porphyria Treatment Market Size by Type
9.2.1 Latin America Swedish Porphyria Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Swedish Porphyria Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Swedish Porphyria Treatment Market Size by Type (2016-2027)
9.3 Latin America Swedish Porphyria Treatment Market Size by Application
9.3.1 Latin America Swedish Porphyria Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Swedish Porphyria Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Swedish Porphyria Treatment Market Size by Application (2016-2027)
9.4 Latin America Swedish Porphyria Treatment Market Size by Country
9.4.1 Latin America Swedish Porphyria Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Swedish Porphyria Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Swedish Porphyria Treatment Market Size (2016-2027)
10.2 Middle East & Africa Swedish Porphyria Treatment Market Size by Type
10.2.1 Middle East & Africa Swedish Porphyria Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Swedish Porphyria Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Swedish Porphyria Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Swedish Porphyria Treatment Market Size by Application
10.3.1 Middle East & Africa Swedish Porphyria Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Swedish Porphyria Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Swedish Porphyria Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Swedish Porphyria Treatment Market Size by Country
10.4.1 Middle East & Africa Swedish Porphyria Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Swedish Porphyria Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Swedish Porphyria Treatment Introduction
11.1.4 Abbott Revenue in Swedish Porphyria Treatment Business (2016-2021)
11.1.5 Abbott Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Swedish Porphyria Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 350mg
Table 3. Key Players of 313mg
Table 4. Global Swedish Porphyria Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Swedish Porphyria Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Swedish Porphyria Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Swedish Porphyria Treatment Market Share by Regions (2016-2021)
Table 8. Global Swedish Porphyria Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Swedish Porphyria Treatment Market Share by Regions (2022-2027)
Table 10. Swedish Porphyria Treatment Market Trends
Table 11. Swedish Porphyria Treatment Market Drivers
Table 12. Swedish Porphyria Treatment Market Challenges
Table 13. Swedish Porphyria Treatment Market Restraints
Table 14. Global Swedish Porphyria Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Swedish Porphyria Treatment Market Share by Players (2016-2021)
Table 16. Global Top Swedish Porphyria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swedish Porphyria Treatment as of 2020)
Table 17. Ranking of Global Top Swedish Porphyria Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Swedish Porphyria Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Swedish Porphyria Treatment Product Solution and Service
Table 21. Date of Enter into Swedish Porphyria Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Swedish Porphyria Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Swedish Porphyria Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Swedish Porphyria Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Swedish Porphyria Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Swedish Porphyria Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Swedish Porphyria Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Swedish Porphyria Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Swedish Porphyria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Swedish Porphyria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Swedish Porphyria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Swedish Porphyria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Swedish Porphyria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Swedish Porphyria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Swedish Porphyria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Swedish Porphyria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Swedish Porphyria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Swedish Porphyria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Swedish Porphyria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Swedish Porphyria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Swedish Porphyria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Swedish Porphyria Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Swedish Porphyria Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Swedish Porphyria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Swedish Porphyria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Swedish Porphyria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Swedish Porphyria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Swedish Porphyria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Swedish Porphyria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Swedish Porphyria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Swedish Porphyria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Swedish Porphyria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Swedish Porphyria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Swedish Porphyria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Swedish Porphyria Treatment Product
Table 64. Abbott Revenue in Swedish Porphyria Treatment Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Swedish Porphyria Treatment Market Share by Type: 2020 VS 2027
Figure 2. 350mg Features
Figure 3. 313mg Features
Figure 4. Global Swedish Porphyria Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Swedish Porphyria Treatment Report Years Considered
Figure 8. Global Swedish Porphyria Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Swedish Porphyria Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Swedish Porphyria Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Swedish Porphyria Treatment Market Share by Regions (2022-2027)
Figure 12. Global Swedish Porphyria Treatment Market Share by Players in 2020
Figure 13. Global Top Swedish Porphyria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swedish Porphyria Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Swedish Porphyria Treatment Revenue in 2020
Figure 15. Global Swedish Porphyria Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Swedish Porphyria Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Swedish Porphyria Treatment Market Share by Type (2016-2027)
Figure 19. North America Swedish Porphyria Treatment Market Share by Application (2016-2027)
Figure 20. North America Swedish Porphyria Treatment Market Share by Country (2016-2027)
Figure 21. United States Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Swedish Porphyria Treatment Market Share by Type (2016-2027)
Figure 25. Europe Swedish Porphyria Treatment Market Share by Application (2016-2027)
Figure 26. Europe Swedish Porphyria Treatment Market Share by Country (2016-2027)
Figure 27. Germany Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Swedish Porphyria Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Swedish Porphyria Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Swedish Porphyria Treatment Market Share by Region (2016-2027)
Figure 37. China Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Swedish Porphyria Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Swedish Porphyria Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Swedish Porphyria Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Swedish Porphyria Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Swedish Porphyria Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Swedish Porphyria Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Swedish Porphyria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Swedish Porphyria Treatment Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Global Swedish Porphyria Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5519 2021年4月 95Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0059 2021年4月 90Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Market Size, Status and Forecast 2021-2027
QYR2104Z0058 2021年4月 98Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入）、用途別市場規模（病院・クリニック、研究センター）、主要地域別市...

世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年）

世界のスティル病治療市場規模・現状・予測（2021年-2027年）

Global Still's Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5451 2021年4月 93Pages
QYResearch社発行の本調査資料では、スティル病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セルトリズマブペゴル、DNX-514、エタネルセプト、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメ...

世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2310 2021年4月 128Pages
QYResearch社発行の本調査資料では、第VIII因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北...

世界の急性間欠性ポルフィリン症市場 2021：企業別、地域別、種類・用途別

Global Acute Intermittent Porphyria Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00327 2021年4月 105Pages
当調査資料では、急性間欠性ポルフィリン症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。急性間欠性ポルフィリン症の種類別市場規模（ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入）、用途別市場規模（病院＆診療所、研究センター）、地域別市場規模（北米...

世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2021-2027
QYR2104Z2520 2021年4月 92Pages
QYResearch社発行の本調査資料では、ムコ多糖症遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、ICV、脳内、大槽内）、用途別市場規模（ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症III型A型、ムコ多糖症型III型B型）...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療薬市場規模・現状・予測（2021年-2027年） Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Therapeutics Market The global Swedis…
世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase. Market Analysis and Insights: Global Acute Intermittent Porphyria Marke…
世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase. Market Analysis and Insights: Global Acute Intermittent Porphyria Marke…